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Orthostatic intolerance is the inability to tolerate the upright posture and is relieved by
recumbence. It most commonly affects young women and has a major impact on quality
of life and psychosocial well-being. Several forms of orthostatic intolerance have been
described. The most common one is the recurrent vasovagal syncope (VVS) phenotype
which presents as a transient and abrupt loss of consciousness and postural tone that
is followed by rapid recovery. Another common type of orthostatic intolerance is the
postural orthostatic tachycardia syndrome (POTS) which is characterized by an excessive
rise in heart rate upon standing and is associated with symptoms of presyncope such
as light-headedness, fatigue, palpitations, and nausea. Maintenance of arterial pressure
under condition of reduced central blood volume during the orthostasis is accomplished
in large part through sympathetic efferent nerve traffic to the peripheral vasculature.
Therefore sympathetic nervous system (SNS) dysfunction is high on the list of possible
contributors to the pathophysiology of orthostatic intolerance. Investigations into the role
of the SNS in orthostatic intolerance have yielded mixed results. This review outlines the
current knowledge of the function of the SNS in both VVS and POTS.
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INTRODUCTION
Orthostatic intolerance is defined by the inability to tolerate the
upright posture. It is usually associated with signs and symptoms
including sensation of warmth, nausea, lightheadedness, dizzi-
ness, fatigue, abdominal pain, and visual blur. If recumbence is
not achieved rapidly, syncope, defined as a temporary loss of con-
sciousness and postural tone, can follow quickly. Syncope resolves
almost immediately when the patient assumes the supine posi-
tion, however after recovery, patients may complain of a “washed
out” and tired feeling (Brignole et al., 2001). Syncope is an
important clinical problem which accounts for approximately 1%
of hospital admissions and 3% of emergency department visits
with a reported mortality and major morbidity rate of over 7%
(Mathias et al., 2001; Colman et al., 2004). Orthostatic intolerance
is often disabling and may cause injury (Calkins and Dp, 2008).
The condition represents a manifestation of many different pro-
cesses and is commonly referred as a symptom, not a disease, and
can be classified according to the underlying cause. The causes of
syncope can be, generally, classified into six groups comprising:
vascular, cardiac, neurological, psychogenic, metabolic, and syn-
cope of unknown origin. The most common cause of syncope in
the general population is the neurally mediated syncope known
as neurocardiogenic syncope, vasovagal syncope (VVS) or simply
“fainting” and has a lifetime cumulative prevalence of 22% (Sun
et al., 2004).
Orthostatic intolerance does not always lead to syncope. Such
is the case for patients with the postural tachycardia syndrome
(POTS), a condition characterized by a heart rate (HR) incre-
ment of 30 beats/min or more within 10min of standing in the
absence of orthostatic hypotension. The orthostatic intolerance in
these patients is typically accompanied by symptoms of cerebral
hypoperfusion similar to those experienced by patients suffer-
ing recurrent VVS but syncope does not occur in many of them
(Nwose et al., 2009). In fact only a third of patients with POTS
have frank syncope, although daily or almost daily pre-syncope
occurs (Nwazue and Raj, 2013). Most patients complain of signif-
icant exercise intolerance and extreme fatigue, even to activities
of daily living. Some patients with POTS also meet diagnostic
criteria for chronic fatigue syndrome (Okamoto et al., 2012).
Maintenance of appropriate blood flow to critical organs on
assumption of upright posture is a major physiological chal-
lenge. This challenge involves a fine balance between neural,
hormonal, and hemodynamic alterations to maintain adequate
arterial pressures. Sympathetic nervous system activity repre-
sents a fast-acting regulatory system that allows adaptation of
the cardiovascular system during changes in posture. The activ-
ity of the sympathetic nervous system (SNS) is primarily reg-
ulated by mechanoreceptors, sensing changes in pressure and,
to a smaller degree, by chemoreceptors. The arterial barore-
ceptors (high pressure receptors) are located in the carotid
sinus and the aortic arch, and cardiopulmonary baroreceptors
(low pressure receptors) are located in the great veins, atria
(A- and B-receptors, Bainbridge reflex), and ventricles (Bezold-
Jarisch reflex). These mechanoreceptors are stretch-activated ion
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channels, which influence sympathetic outflow (Chapleau et al.,
1995). The carotid sinus and aortic depressor nerves convey pri-
mary baroreceptor afferent information to regions of the nucleus
of the solitary tract (for review, see Vasquez et al., 1997).
In humans, normal baroreflex physiology in response to
decreased venous return during upright posture involves,
increased vascular sympathetic nerve activity, and decrease in
parasympathetic activity, resulting in an increase in heart rate
and contractility, and an increase in peripheral vasoconstriction
(Rowell, 1993). These normal responses result in maintenance
of arterial pressure during upright posture and protection of
cerebral perfusion thereby preventing symptoms such as those
reported by patients suffering from recurrent syncope or in those
with POTS.
Given the importance of sympathetic nervous regulation in
response to changes in posture, the cause of orthostatic intol-
erance has been thought to involve various degrees of sympa-
thetic dysfunction. As the SNS is central to the neurocirculatory
response to posture, it has been assumed that these neural mecha-
nisms fail in orthostatic intolerance. This review will focus on the
current knowledge of sympathetic dysfunction, in two common
types of orthostatic intolerance: VVS and the POTS.
NEURO-HORMONAL CHANGES ON STANDING
Changing posture from supine to standing leads to a rapid pool-
ing of 300 to 800ml of blood in the lower extremities and to the
pelvic region causing thoracic hypovolemia due to an abrupt drop
in venous return to the heart hence decreasing the ventricular
preload. This fall in preload leads to a decrease in cardiac output
(CO) and to less distention of the aortic arch and carotid sinus
baroreceptors and subsequently reduced afferent baroreflex traf-
fic to the brainstem. The unloading of the baroreceptors triggers
reciprocal changes in autonomic activity with parasympathetic
inhibition and sympathetic activation resulting in an increase
in both HR and total peripheral resistance in order to mini-
mize orthostatic reduction in blood pressure (BP). Increased fluid
absorption has also been described in response to the increases
in peripheral vascular resistance (Hinghofer-Szalkay et al., 1992).
The cardiopulmonary baroreflexes are simultaneously unloaded
to potentiate the actions of the arterial reflexes (Victor and Mark,
1985). Normally, orthostatic stress evokes compensatory vaso-
constriction across multiple vascular beds including the skeletal
muscle, which can be recorded as muscle sympathetic nerve activ-
ity (MSNA) in humans (Figure 1A). In response to graded tilt,
MSNA of healthy individuals increases and correlates with the
degree of the tilt angle (Mosqueda-Garcia et al., 1997). Jacob et al.
(1998) studied the neurohumoral changes in response to standing
in healthy individuals and noted a rapid and sustained increase in
noradrenaline spillover, most likely as a result of both increased
nerve firing and a reduction in norepinephrine plasma clearance
(Meredith et al., 1992). This surge in noradrenaline preferen-
tially binds α1-adrenoceptors to cause smoothmuscle contraction
and vasoconstriction. In parallel, a transient rise in plasma con-
centrations of adrenaline, steady elevation of plasma aldosterone
concentration as well as an increase in the renin angiotensin
system activity were noted. These responses were found to cor-
relate to the physiological orthostatic hypovolemia indicated by a
FIGURE 1 | Examples of heart rate (HR), blood pressure (BP) and
muscle sympathetic nerve activity (MSNA) during supine rest and
30 degree tilt in one healthy control (A), one patient with recurrent
vasovagal syncope (B), and one patient with postural tachycardia
syndrome (C). Adapted from Vaddadi et al. (2007).
decrease in plasma volume reaching 13% after 14min of stand-
ing. The hypovolemia is driven by the intravascular shift of fluid
derived from the central compartment to the lower extremities
and the pelvic region. The BP in the upright posture reached
a nadir soon after the HR and plasma adrenaline peak. Plasma
arginine vasopressin level rose with a time course similar to
that of plasma renin activity. The rise in plasma renin activity
and aldosterone release could exert numerous effects to main-
tain posture: increasing tubular Na+ reabsorption at the level
of the kidney, direct vasoconstriction at the level of the vascu-
lar smooth muscle, and enhancement of noradrenaline release by
actions on the presynaptic noradrenergic neurons and possibly
also at the level of the central nervous system (Jacob et al., 1998).
In addition, it is recognized that adrenaline can exert signifi-
cant effects, particularly on α2- and β2-adrenoreceptors (humoral
receptors) in the circulation, while also having effects on α1- and
β1-adrenoreceptors (neuronal receptors) (Hoffman et al., 1995).
The strong correlation between the HR and adrenaline level
described by Jacob et al. (1998) suggests that adrenaline may be
an important modulator of HR change in the first few minutes of
standing.
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THE ASSESSMENT OF PRE-SYNCOPE AND SYNCOPE
VVS is not generally associated with cardiovascular, neurological,
or other diseases, and, therefore, represents an isolated manifes-
tation. It is usually mediated by emotional or orthostatic stress. It
is diagnosed when precipitating events such as fear, severe pain,
emotional distress, instrumentation, or prolonged standing are
associated with typical prodromal symptoms (Alboni et al., 2004).
Classical VVS generally starts at a young age, the most common
age at which it first presents is 13 years (Sheldon et al., 2006). The
overall incidence of syncope in individuals aged 30–62 years over
a 26-year period was reported to be 3.3%. (Savage et al., 1985).
The incidence is thought to increase with age, and in elderly
patients in long-term nursing facilities it is approximately 6%
(Lipsitz et al., 1986). In 30% of patients syncopal episodes are
recurrent (Lipsitz et al., 1986).
Syncope is driven by an acute fall in mean BP to less than
40mmHg that causes a transient interruption of cerebral blood
flow for more than 8 s (Manolis et al., 1990). VVS results from
excessive arteriolar dilation and inappropriate bradycardia. The
sequence of events occurring during VVS is still not very well
understood despite the many investigations that have been con-
ducted (Kaufmann, 1995). The assessment of the underlying
pathophysiological mechanisms leading to VVS has been difficult
to determine because syncope may occur randomly and patients
are generally otherwise healthy and as there are no convincing
reports on reflex syncope in animals (Van Dijk, 2003), there is no
perfect animal model for reflex syncope. The distinction between
VVS and other causes of fainting is however essential, as the prog-
nosis and treatment are different. The use of tilt table testing has
facilitated the evaluation of the possible mechanisms underlying
the differing forms of orthostatic intolerance. Tilt table testing
induces orthostatic stress, resulting in maximal venous pooling,
central hypovolaemia, and provocation of vasovagal syncope. The
caveats of this test include limited activation of the muscle pump
in the lower limbs and the fact that it is not uncommon for
non-orthostatically intolerant patients to return positive results.
Nevertheless the test is generally accepted to reproduce vasovagal
syncope in the laboratory setting (Parry and Kenny, 1999). Lower
body negative pressure (LBNP) has also been useful in identify-
ing possible physiological mechanisms associated with syncope
(Bechir et al., 2003) although it is recognized to more closely
simulate hemorrhage (Convertino, 2001). Lately, it was argued
that combining passive tilt testing with LBNP provided the best
approach for diagnosis for VVS (Protheroe et al., 2013); this com-
bined method is used in a few laboratories (Patwardhan et al.,
2001; Batzel et al., 2009). The understanding of the pathophys-
iology underlying VVS is further complicated by the fact that
many mechanistic evaluations have been conducted in healthy
individuals who develop syncopal episodes exclusively during a
tilt test or LBNP. This is an important consideration given that
well-defined differences in hemodynamic characteristics between
patients with recurrent syncope and healthy subjects who faint
only when tilted have been established (Mosqueda-Garcia et al.,
1997). Julu et al. (2003) described in ten patients the cardio-
vascular events leading up to pre-syncope. They showed that
progressive orthostatic stress triggers a succession of BP and HR
reactions that are independent of the subject’s tolerance. These
reactions can be categorized into four response phases including
(1) full compensation, (2) tachycardia, (3) BP instability, and (4)
pre-syncope. Although the mechanisms responsible for the devel-
opment of syncope were uncertain, the authors postulated that
it may result from an increase in sensitivity and resetting of the
arterial baroreceptors functions.
PARADOXICAL COMPENSATORY REFLEX AS A CAUSE
OF VVS
The ventricular theory postulates that baroreceptors react to a
decrease in BP by sympathetic nervous activation leading to
greater cardiac inotropy, chronotropy, and peripheral vasocon-
striction (Thoren, 1979). It has first been proposed that vigorous
contractions of a volume-depleted ventricle leads to activation
of the cardiac C fibers (non-myelinated fibers, found in the
atria, ventricles and pulmonary artery). Stimulation of these
afferent C fibers leads to a “paradoxical” withdrawal of periph-
eral sympathetic tone and an increase in vagal tone, which,
in turn causes vasodilation and bradycardia (Kaufmann, 1995).
Contrary to this view, by using echocardiographic measurements
of left cardiac chamber size and stroke volume, Novak and
colleagues found no evidence of progressive cardiac emptying
before the onset of syncope (Novak et al., 1996). Furthermore,
assessment of left ventricular wall stress and segmental wall
thickening preceding syncope showed no evidence compatible
with activation of left ventricular mechanoreceptors (Liu et al.,
2000).
SYMPATHETIC RESPONSE TO ORTHOSTATIC STRESS AND
SYMPATHETIC WITHDRAWAL DURING VVS
Earlier studies have suggested that the vasodilation seen dur-
ing VVS results from a withdrawal of sympathetic tone (Wallin
and Sundlof, 1982; Van Lieshout et al., 1991). To assess this
issue, direct measurements of sympathetic activity have been
performed in patients using either direct recording of MSNA
or noradrenaline isotope dilution methodology (spillover).
Microneurography is highly reproducible and minimally inva-
sive compared with the noradrenaline spillover technique, and
offers the advantage that changes in sympathetic activity, BP
and HR can be observed continuously, permitting the temporal
association between variables to be evaluated. However, record-
ing sites are often compromised when loss of postural tone
occurs (Vaddadi et al., 2010). In earlier studies, since a progres-
sive or abrupt withdrawal of MSNA before vasovagal syncope
was observed (Morillo et al., 1997; Jardine et al., 1998), it was
assumed that reduced sympathetic activity might play a causal
role in orthostatic intolerance. In the study from Jardine et al.
(1998), the fall in MSNA during presyncope correlated directly
with mean BP, whereas parasympathetic activity (as measured
by spectral analysis of heart rate variability) remained below
baseline, suggesting that sympathetic control of total peripheral
resistance was the predominant mechanism of vasovagal syn-
cope. Muscle sympathetic nerve responses during progressive
head up tilt have been examined by several investigators and
results vary. Mosqueda-Garcia et al. (1997) found that the initial
sympathetic response to change in circulating volume is differ-
ent between patients and controls, as they noted that the MSNA
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increase in patients was severely reduced. Patients also exhibited
a reduction in maximal increase in MSNA and plasma nora-
drenaline responses that were inadequate to compensate for the
significant fall in arterial BP. These response were also followed
by progressive MSNA inhibition followed by nerve silencing
and subsequent syncope. In these patients, significant reductions
in baroreflex responses were observed in the supine position
as assessed with phenylephrine and sodium nitroprusside infu-
sions. Decreased baroreflex function was therefore proposed to
explain the inability of these patients to increase sympathetic
outflow in response to reductions in pressure. These results are
in line with those from Bechir et al. (2003) who also reported
an impaired MSNA in response to LBNP in patients with VVS.
These patients also displayed blunted baroreflex function but
were however characterized by elevated baseline MSNA. Elevated
baseline sympathetic modulation of vasomotor tone in these
patients may exhaust their reserve to increase sympathetic mod-
ulation of vasomotor tone and peripheral resistance any further
during an orhtostatic challenge (Sneddon et al., 1993). During
routine clinical autonomic testing we observed that of the 10
patients where a MSNA recording site was maintained, only 1
patient demonstrated an abrupt cessation of MSNA at the onset
of haemodynamic compromise (Vaddadi et al., 2010). All other
subjects demonstrated preserved MSNA, an observation that was
entirely unexpected (Figure 1B). This study challenged the notion
that near-total sympathetic withdrawal, as defined by cessation
of MSNA, is the final common trigger that results in hypoten-
sion during VVS. This finding of persistent nerve firing during
the syncopal event in all but 1 of 10 patients is supported by
observations of Cooke et al. (2009) who applied LBNP to healthy
individuals to simulate hemorrhage and noted that MSNA was
maintained throughout cardiovascular collapse in 40% of their
subjects.
SYMPATHETIC NERVE PROTEINS DEFICIENCIES IN VVS
Given that patients with VVS have been reported to present two
clinical phenotypes: normal systolic BP (>100mmHg) and low
systolic BP (70–100mmHg) (Mathias et al., 2001), we compared
sympathetic responses in these two distinctive groups and noticed
that among patients with recurrent VVS, those with normal BP
had normal MSNA at supine rest and displayed a normal MSNA
response to tilt while those with low BP had an exaggerated
MSNA response to tilt (Vaddadi et al., 2011). In addition, low BP
patients presented with low baseline whole body noradrenaline
spillover to plasma. Both patient groups had a severely blunted
noradrenaline spillover response to head up tilt, with no increase
in noradrenaline spillover to plasma indicating a failure of SNS
response to postural change. In those with low BP, noradrenaline
spillover was significantly lower at all tilt angles compared with
healthy subjects and in those patients with normal BP. The finding
of low noradrenaline spillover in low BP subjects contrasts with
their marked increase in MSNA indicating a “mismatch” between
nerve firing and noradrenaline release. A similar mismatch was
present in patients with normal BP who had a normal increase in
MSNA during HUT, but no increase in noradrenaline spillover.
This “mismatch” between nerve firing and noradrenaline release
was further investigated with analysis of sympathetic nerve pro-
teins involved in noradrenaline synthesis, storage, release, and
reuptake (see Figure 2). Proteins were harvested from subcuta-
neous vein biopsies obtained from the forearm in patients on
a separate day of the main investigation (Vaddadi et al., 2011).
Quantification of the key regulatory proteins tyrosine hydroxylase
FIGURE 2 | Sympathetic nerve varicosity. Tyrosine hydroxylase (TH)
catalyzes the rate limiting step in norepinephrine (NE) synthesis. NE is stored
in vesicles within the sympathetic varicosity and released to effector sites
such as arterioles and venules in response to muscle sympathetic nerve
firing (MSNA). Norepinephrine transporter (NET) recaptures 60–95% of
released NE, and, of this, 70–90% is returned to intraneuronal vesicular
storage. Vesicular monoamine transporter (VMAT2) is responsible for
translocating NE from the cytoplasm into storage vesicles and is specific for
sympathetic nerves. Dynamins are ubiquitous GTPases that support vesicular
budding and fusion. Adapted from Vaddadi et al. (2011).
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(TH), the rate-limiting enzyme in noradrenaline synthesis, and
the noradrenaline transporter (NET), revealed that patients with
low BP had a reduced level of both TH and NET while those with
normal BP had increased NET expression. The origin of aber-
rant sympathetic nerve protein expression is unknown; however
the nerve protein profile is likely to contribute to the abnormal
response during head up tilt with subsequent orthostatic intoler-
ance and syncope. The pathogenesis of VVS may lie at the level of
sympathetic nerve proteins which regulate neurotransmitter dis-
position. The NET is responsible for clearing noradrenaline from
the sympathetic nerve synaptic space, thus terminating the neu-
ral signal. Increased expression of NET may clear noradrenaline
more rapidly, reducing neural compensatory vasoconstriction,
and so predisposing to postural hypotension.
CARDIAC OUTPUT
An alternative hypothesis is that the cardiac output (CO) fall is
the predominant physiological event that determines hypoten-
sion. In a study of 56 patients presenting with suspected VVS
who underwent head up tilt, stroke volume was computed from
pressure pulsation data (Verheyden et al., 2008). There was a 50%
reduction in calculated CO while systemic vascular resistance was
maintained until pre-syncope. There occurred no difference in
BP and HR response between VVS that was provoked by sublin-
gual glyceryl trinitrate compared to those with a non-provoked
VVS. On the other hand, an earlier study (Stevens, 1966) showed
no exaggerated diminution in CO during early tilt in subjects
who developed syncope between 10 and 18min later. Jardine
et al. (2002) noticed that although CO fell in all subjects dur-
ing the first minute of tilt, the patients who became hypotensive
were characterized by a further accelerated decline in CO, which
began some minutes before syncope. Patients who developed
syncope failed to maintain CO despite similar left ventricular fill-
ing pressures and lower total peripheral resistance. Jardine et al.
(2002) postulated that partial MSNA withdrawal mediates ven-
odilation resulting in decreased CO and mild hypotension early
in the vasovagal reaction, whereas total MSNA withdrawal medi-
ates arteriolar vasodilation, resulting in severe hypotension and
syncope. Low COmay play an important role in the development
of some episodes of VVS, but its position as the prime mover
in this condition remains controversial. While studying healthy
individuals developing syncope during a tilt test, Fu et al. (2012)
noticed that the CO response varied before the onset of syncope.
These authors observed a moderate fall in CO with coincident
vasodilatation in the majority (64%) of the presyncopal subjects
and a marked fall in CO, driven predominantly by a decrease in
HR, with no changes in total peripheral resistance at presyncope
occurring in a smaller (36%) subset. In parallel, when MSNA
withdrawal occurred, it was a late event, observed after the onset
of hypotension. In addition, most likely because subjects were
healthy, sympathetic vasoconstriction and baroreflex sensitivity
during symptom-free tilting were well preserved and, thus, an
intrinsic impairment of sympathetic neural control and vasomo-
tor responsiveness was suggested not to be the cause of neurally
medicated (pre)syncope in this population. Instead, this study
pointed to the fact that presyncope and syncope may be driven
by a steep fall in CO.
STRUCTURAL CHANGES IN THE CENTRAL NERVOUS
SYSTEM
Using magnetic resonance imaging voxel-based morphometry
analysis, one recent study indicated a reduction of medullary
volume in patients with VVS, encompassing the nucleus of
the solitary tract and the caudal midline medulla, two regions
of particular interest as pathological disturbance of the struc-
tural integrity of these nuclei could potentially affect autonomic
function (Beacher et al., 2009). More recently, using the same
approach, this finding was not replicated, but patients with VVS
presented with regional atrophy in the right insular cortex as
well as a significant reduction of whole right insular volume
compared with controls (Kim et al., 2014). Since the insular
cortex is recognized as playing a crucial role in cardiovascu-
lar modulation in particular parasympathetic autonomic tone
and BP fluctuations (Nagai et al., 2010), such a defect was sug-
gested to be associated with a decrease in sympathetic activity
and a reciprocal increase in parasympathetic activity, resulting
in cerebral hypoperfusion and syncope. Although results are at
variance, these studies suggested that VVS may be associated with
structural changes of brain nuclei controlling autonomic regula-
tion, which predisposes the patient to abnormal cardiovascular
homeostasis and recurrent syncope. Whether possible structural
changes are an actual cause or consequence of repeated bouts
of cerebral hypoperfusion associated with syncope remains to be
determined.
THE ASSESSMENT OF THE POSTURAL ORTHOSTATIC
TACHYCARDIA SYNDROME (POTS)
Clinical observations show that individuals with POTS repre-
sent a highly heterogenous group of patients (Benarroch, 2012).
Earlier studies suggested that approximately one-half of patients
have an antecedent, presumed viral illness (Schondorf and Low,
1993), although recent experience suggests that this is less com-
mon. Typical symptoms of complaints from POTS patients may
include headache, poor concentration, dizziness, fatigue, tremor,
chest discomfort, and shortness of breath. Many patients with
POTS report a cyclical nature of their symptoms but, of note,
also report symptoms not attributable to orthostatic intoler-
ance, including those of functional gastrointestinal or bladder
disorders, chronic headache, fibromyalgia, and sleep distur-
bances. In many of these cases, cognitive and behavioral factors,
somatic hypervigilance associated with anxiety, depression, and
behavioral amplification may contribute to symptom chronic-
ity (Benarroch, 2012).While the diagnostic criteria focus on the
abnormal HR increase upon standing, POTS usually presents
with symptoms much more complex than a simple, albeit exag-
gerated, increase in HR. It is fairly common for POTS patients
to have a noticeable drop in BP upon standing, but some POTS
patients have no change or even an increase in BP upon stand-
ing (Grubb, 2008). Given the heterogeneity of this condition,
understanding the underlying mechanisms of the tachycardia has
proven challenging. Abnormal sympathetic nervous activity or
reactivity may be central to the condition; however there is still
no definite answer as to whether the excessive tachycardia with
orthostasis in POTS patients is the cause or a consequence of
sympathetic nervous dysfunction.
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SYMPATHETIC DENERVATION MAY BE ASSOCIATED
WITH POTS
There is evidence that some patients with POTS present with
peripheral sympathetic denervation in the lower limbs. This is
characterized by blunted noradrenaline release in the lower limb
in response to orthostatic stress and loss of sweating in the feet on
thermoregulatory sweat tests and quantitative sudomotor axon
reflex testing (Jacob et al., 1999). Examination of medical records
of patients with POTS seen at the Mayo Clinic in Rochester indi-
cated that half of the patients had evidence of peripheral sudomo-
tor denervation as estimated by abnormal sudomotor axon reflex
test and thermoregulatory sweat test (Thieben et al., 2007). The
primary pathophysiologic mechanism of postural intolerance in
this subgroup of patients is presumed to be impaired peripheral
vasoconstriction, leading to venous pooling in the lower limbs.
Consistent with this possibility, a subgroup of patients with POTS
have impaired indirect measures of sympathetic vasoconstriction
as assessed from the BP profile during the Valsalva maneuver or
head up tilt (Thieben et al., 2007). It was also noted that in some
cases of POTS there was a defective vasoconstriction that pro-
duces resting venous hypertension and venous congestion, but
it was not associated with abnormalities in the volume-pressure
relations or overall venous capacitance while supine or during
orthostasis (Stewart, 2002). This neuropathic subgroup, termed
“high-flow” POTS, was characterized by reduced total peripheral
resistance while supine and venous pooling in the legs on stand-
ing (Medow and Stewart, 2007). More recent investigations have
focused on possible aberrant cardiac sympathetic innervation.
Reduced myocardial meta-iodobenzylguanidine uptake indicat-
ing reduced cardiac sympathetic neuronal uptake function has
been reported in 20% of patients with POTS, suggesting that car-
diac sympathetic denervation may be present in this condition
(Haensch et al., 2010). More recently it was also demonstrated
that reduced myocardial meta-iodobenzylguanidine uptake cor-
related with the density of sympathetic and somatic C-fiber inner-
vation measured from skin biopsies and suggested that loss of
distal sympathetic innervation may produce an exaggerated sym-
pathetic response in innervated tissues such as the heart, resulting
in tachycardia (Haensch et al., 2014).
SYMPATHETIC OVERACTIVITY MAY BE ASSOCIATED
WITH POTS
Some investigations (Streeten et al., 1988; Schondorf and Low,
1993; Furlan et al., 1998; Jacob et al., 1999), but not all (Jacob
et al., 2000; Lambert et al., 2008), have reported that POTS
patients have greater systemic plasma noradrenaline concentra-
tions at rest or during orthostasis compared with healthy controls,
suggesting that POTS is associated with a hyperadrenergic state.
More robust and precise assessment of sympathetic activity by
direct measurements of total body and regional noradrenaline
spillover have been performed in a few investigations and the
results have been variable. Evidence of sympathoexitation was
confirmed in one study (Jordan et al., 2002), but not in oth-
ers (Jacob et al., 1999; Goldstein et al., 2002a; Lambert et al.,
2008). The possible hyperadrenergic features of POTS may not
be simply due to increased central sympathetic outflow and nora-
drenaline release but potentially from an augmentation of the
sympathetic signal due to enhanced receptor sensitivity or to a
reduction in noradrenaline clearance during standing. One study
found no evidence for a substantial increase in the sensitivity to
adrenoreceptor stimulation during complete ganglionic blockade
with trimethaphan indicating that the hyperadrenergic features of
POTS could not be completely explained by systemic hypersen-
sitivity of postsynaptic α1- and β-adrenoreceptors (Jordan et al.,
2002). On the other hand, decreased noradrenaline clearance with
standing was observed in POTS patients, suggesting that much
of the increase in plasma noradrenaline was due to a decrease
in clearance (Jacob et al., 1999), although reduced noradrenaline
plasma clearance during head up tilt testing is not uncommon
(Meredith et al., 1992). In addition, in the investigation by Jacob
and colleagues, patients were hypersensitive to the heart rate-
increasing effect of bolus injections of isoproterenol suggesting
apparent β-adrenergic receptor hypersensitivity. The only study
investigating cardiac sympathetic activity using measures of car-
diac noradrenaline spillover to plasma indicated elevated cardiac
sympathetic drive in patients with POTS (Goldstein et al., 2002a).
The tachycardia in the upright position of POTS therefore may
partly reflect increased noradrenaline delivery to adrenoceptors
on myocardial pacemaker cells combined with a reduced synap-
tic clearance by NET, thereby potentiating the sympathetic neural
signal.
The inconsistency of the results may reflect the highly recog-
nized heterogeneity of patients with POTS (Benarroch, 2012).
When assessed using MSNA, sympathetic tone has also been
shown to be highly variable in POTS patients. For example one
study reported that patients with POTS had increased resting
MSNA, decreased responsiveness to head up tilt and similar
supine MSNA baroreflex gain values (via vasoactive drug infu-
sions) compared with healthy control subjects (Furlan et al.,
1998). Contrasting results were found by Muenter Swift et al.
(2005) who found that POTS patients had exaggerated MSNA
responses to baroreflex challenges compared with control sub-
jects, although resting supineMSNA values did not differ between
the groups. By combining MSNA and total body noradrenaline
spillover we found no evidence of sympathetic activation in POTS
patients in the supine position as both resting MSNA and total
body noradrenaline spillover were similar to that of controls
(Lambert et al., 2008). However, an excessive nerve firing response
was observed during tilt (Figure 1C) but this was unexpectedly
not matched by enhanced noradrenaline spillover.
ALTERED NET EXPRESSION IN POTS
Neuronal reuptake of noradrenaline via the cell membrane NET
(uptake-1) is the main means of inactivation of noradrenaline
in the heart and a key factor in regulation of delivery of nora-
drenaline to myocardial adrenoceptors (Eisenhofer et al., 1991).
Jordan et al. (2002) first noticed that POTS patients had reduced
plasma 3,4-dihdroxyphenylglycol (DHPG)/ noradrenaline ratios.
Although the majority of DHPG in plasma is derived from
metabolism of noradrenaline that leaks from storage vesicles
(Eisenhofer et al., 2004) given that DHPG is produced intra-
neuronally via the action of monoamine oxidase this measure
has been used as an indicator of the efficiency of the neuronal
uptake of noradrenaline (Goldstein et al., 1988). Reinforcing
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the possibility that a defect in NET may be involved in the
pathophysiology of POTS, selective NET blockade in healthy
individuals creates a phenotype that resembles POTS (Schroeder
et al., 2002). The first indication that altered NET activity was
implicated in the hyperadrenergic state observed in POTS came
from the study of a 33-year-old female with a 20-year history
of POTS (Shannon et al., 2000). In response to upright posture,
she experienced a 4-fold increase in plasma noradrenaline, but
only a doubling of muscle sympathetic nerve activity, indicat-
ing an electrochemical dissociation in the sympathetic neuron. A
point mutation in the coding region of the NET gene (SLC6A2)
was identified that encoded a dysfunctional protein with dra-
matically reduced noradrenaline reuptake compared to wild-type
NET. While neither this mutation, nor single nucleotide poly-
morphisms (SNPs) in the NET gene have been found in other
unrelated POTS patients (Ivancsits et al., 2003), we have found
that some POTS patients have decreased NET protein expres-
sion when compared with healthy subjects (Lambert et al., 2008).
Previous work from our group has noted the possible impor-
tance of epigenetic mechanisms in NET regulation. While an
early report suggested that hypermethylation of the NET gene
(SLC6a2) may lead to transcriptional repression of SLC6a2 (Esler
et al., 2006), recent reports using more specific and robust
methodology have found no evidence of methylation of the pro-
moter of the NET gene (Bayles et al., 2013). Although methyl
CpG binding protein (MeCP2) induced transcriptional repres-
sion of genes was originally proposed to be dependent on DNA
methylation, recent studies, including our own, have established
that this is not always the case (Bayles et al., 2010, 2012). Indeed,
the expression of NET may be regulated independently of pro-
moter DNA methylation, by mechanisms involving the binding
of the transcription repressor MeCP2 and modification of his-
tone tails (Bayles et al., 2010, 2012). Taken together, while these
results do point to some involvement of NET in the pathophysi-
ology of POTS data from Goldstein et al. (2002b) indicated that,
at least in the supine position, cardiac extraction of 3H-labeled
noradrenaline was not reduced, which suggests that high cardiac
noradrenaline spillover was more likely due to increased cardiac
sympathetic firing and high noradrenaline release rather than
decreased noradrenaline reuptake. While evidence of reduced
whole body noradrenaline plasma clearance are evident dur-
ing head up tilt, whether changes in cardiac NET function are
observed during orthostatic challenge remains to be determined.
CONCLUSION
Both VVS and POTS are important clinical problems and
although often generally considered benign conditions, frequent
and recurrent episodes of syncope or presyncope can negatively
affect quality of life and are associated with substantial mor-
bidity. Understanding the pathophysiology of these conditions
has proven difficult. VVS may result from withdrawal of sym-
pathetic tone, baroreflex failure, a fall in the CO or a combina-
tion of both. POTS on the other hand may involve sympathetic
denervation in the lower limbs, a hyperadrenergic state and/or
abnormalities in the NET. While sympathetic dysfunction may
be center to both conditions, results from studies are diver-
gent whichmost likely reflects the pathophysiologic heterogeneity
of orthostatic intolerance and the presence of multiple comor-
bidities not directly related to the actual orthostatic stress. It is
therefore not surprising that patients with orthostatic intoler-
ance pose a particular challenge in terms of management. Various
drugs acting on sympathetic activity have been used. For example,
β-blockers are proposed to reduce the degree of mechanorecep-
tor activation and block the effects of circulating catechoamines.
In patients with VVS, the evidence for the use of β-blockers is
however scant and of dubious quality (Parry and Kenny, 1999).
In POTS patients β- blockers have been reported to be a useful
treatment for individuals with β-receptor super-sensitivity, high
noradrenaline levels and/or hyper-adrenergic states but their use-
fulness remain uncertain (Abed et al., 2012). Alpa-agonists such
as midodrine work by increasing peripheral vascular resistance
and reducing vascular capacitance (to cause increased venous
return) and have been shown to be effective for patients with VVS
(Ward et al., 1998). Nevertheless, despite the knowledge that sym-
pathetic dysfunction is present in orthostatic intolerance, target-
ing sympathetic activity remains difficult and at present, optimal
therapy still focuses on education, salt and volume management,
physical counter-maneuvers and exercise.
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